Sequential Versus Concurrent Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for N3 Limited-Stage Small-Cell Lung Cancer

At present, concurrent chemoradiotherapy (CRT) is considered the standard treatment of limited-stage small cell lung cancer (LS-SCLC). However, LS-SCLC is highly heterogeneous in the T stage, N stage, and prognosis. Increasing evidence has shown that individual treatment should be considered when tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhenbo, Wan, Jinliang, Liu, Changmin, Li, Lei, Dong, Xinjun, Geng, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791450/
https://www.ncbi.nlm.nih.gov/pubmed/32951452
http://dx.doi.org/10.1177/1073274820956619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791450/
https://www.ncbi.nlm.nih.gov/pubmed/32951452
http://dx.doi.org/10.1177/1073274820956619

Ejemplares similares